TOXIC EFFECT OF A BETA-AMYLOID PEPTIDE (BETA-22-35) ON THE HIPPOCAMPAL NEURON AND ITS PREVENTION

被引:81
|
作者
TAKADERA, T
SAKURA, N
MOHRI, T
HASHIMOTO, T
机构
[1] Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa
关键词
BETA-AMYLOID PROTEIN; HIPPOCAMPAL NEURON; NEUROTOXICITY; INSULIN; CAMP;
D O I
10.1016/0304-3940(93)90135-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A synthetic truncated beta-amyloid peptide, beta22-35, was shown to have a cytotoxic effect on cultured neurons from the rat hippocampus in serum-free medium. The peptide formed aggregates and typical amyloid fibrils resembling those of the beta-amyloid protein (AP) in neutral buffer solution and showed characteristic staining with Congo red and thioflavin-S. The neurotoxicity of beta22-35 was suppressed by addition of calf serum, dibutyryl cAMP or insulin to culture medium, but not by addition of NGF or substance P. Beta22-35 had no effect on the glial cells. These results suggest that the AP can induce neurotoxicity in the hippocampal cells in vitro and the toxicity may involve a disorder in the intracellular signal transduction.
引用
收藏
页码:41 / 44
页数:4
相关论文
共 50 条
  • [41] Neuropathology of synthetic beta-amyloid peptide analogs in vivo
    Chen, SY
    Harding, JW
    Barnes, CD
    BRAIN RESEARCH, 1996, 715 (1-2) : 44 - 50
  • [42] Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons
    Prehn, JHM
    Bindokas, VP
    Jordan, J
    Galindo, MF
    Ghadge, GD
    Roos, RP
    Boise, LH
    Thompson, CB
    Krajewski, S
    Reed, JC
    Miller, RJ
    MOLECULAR PHARMACOLOGY, 1996, 49 (02) : 319 - 328
  • [43] ALZHEIMER BETA-AMYLOID PEPTIDE-25-35 - ELECTROSTATIC INTERACTIONS WITH PHOSPHOLIPID-MEMBRANES
    TERZI, E
    HOLZEMANN, G
    SEELIG, J
    BIOCHEMISTRY, 1994, 33 (23) : 7434 - 7441
  • [44] Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide25-35 and Cholinesterase Inhibitory Property of Its Bioactive Compounds
    Shanmuganathan, Balakrishnan
    Malar, Dicson Sheeja
    Sathya, Sethuraman
    Devi, Kasi Pandima
    PLOS ONE, 2015, 10 (11):
  • [45] BETA-AMYLOID PROTEIN PROMOTES NEURITIC BRANCHING IN HIPPOCAMPAL CULTURES
    WHITSON, JS
    GLABE, CG
    SHINTANI, E
    ABCAR, A
    COTMAN, CW
    NEUROSCIENCE LETTERS, 1990, 110 (03) : 319 - 324
  • [46] Minimising the toxic effects of beta-Amyloid 42 on oxidative stress
    Hussien-Ali, Alaa
    Alifragis, Pavlos
    BIOCHEMICAL PHARMACOLOGY, 2017, 139 : 133 - 134
  • [47] INVIVO NEUROTOXICITY OF BETA-AMYLOID [BETA(1-40)] AND THE BETA(25-35) FRAGMENT
    KOWALL, NW
    MCKEE, AC
    YANKNER, BA
    BEAL, MF
    NEUROBIOLOGY OF AGING, 1992, 13 (05) : 537 - 542
  • [48] Inhibitory effect of monoclonal antibodies on Alzheimer's beta-amyloid peptide aggregation
    Hanan, E
    Solomon, B
    AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1996, 3 (02): : 130 - 133
  • [49] FAILURE OF BETA-AMYLOID PROTEIN-FRAGMENT 25-35 TO CAUSE HIPPOCAMPAL DAMAGE IN THE RAT
    STEINBEHRENS, B
    ADAMS, K
    YEH, M
    SAPOLSKY, R
    NEUROBIOLOGY OF AGING, 1992, 13 (05) : 577 - 579
  • [50] Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning
    Holscher, Christian
    Gengler, Simon
    Gault, Victor A.
    Harriott, Patrick
    Mallot, Hanspeter A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 561 (1-3) : 85 - 90